Nanobiotix reports Phase 1 JNJ-1900 results in 24 lung cancer patients, including 79% one-year locoregional control and no ...

AstraZeneca and Daiichi Sankyo’s ENHERTU cut progression or death risk by 37% and delivered 14.3-month median PFS in ...

Novo Nordisk adopts Novo for day-to-day communication, launches “Lasting Health Starts Now” and introduces a new cultural ...

AstraZeneca reports eight-year ADAURA data showing TAGRISSO reduced death risk by 48% across Stage IB-IIIA EGFR-mutated lung ...

Whitehawk Therapeutics reports WCLC 2026 analyses showing stable PTK7 expression in pretreated EGFR wild-type lung cancer, ...

Johnson & Johnson reports final PAPILLON results showing 34.3-month median survival with RYBREVANT plus chemotherapy versus ...

Takeda’s zasocitinib NDA receives FDA Priority Review for moderate-to-severe plaque psoriasis after Phase 3 trials met key endpoints.

Cullinan and Taiho report Phase 3 REZILIENT3 data showing zipalertinib plus chemotherapy improved median PFS by six months in ...

Brent and WTI crude remain above $100 per barrel as Middle East shipping disruptions and supply concerns drive market ...

TotalEnergies acquires the remaining 35% stake in the Grandpuits advanced plastics recycling plant, expanding its recycling ...

VinFast reports 20,161 electric vehicle deliveries in Vietnam for August 2026, with VF 3 leading sales and 154,073 EVs ...

MoneyHero Group reports Q2 2026 revenue of US$15.8 million, lower expenses, improved EBITDA loss, and stronger wealth product ...